Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person8
Estrella Immunopharma, Inc.
Company
Lyell Immunopharma, Inc.
Company
Immix Biopharma, Inc.
Company
Immunome Inc.
Company
GT Biopharma, Inc.
Company
Cue Biopharma, Inc.
Company
IGC Pharma, Inc.
Company
Immunovant, Inc.
Company
Primary record7
Estrella Immunopharma, Inc. filed 4
SEC form 4 filed by Estrella Immunopharma, Inc. (CIK 1844417) on 2026-11-04.
Estrella Immunopharma, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 25, 2026, the Board of Directors (the “Board”) of Es
Estrella Immunopharma, Inc. filed 8-K
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 1, 2026, Estrella Immunopharma, Inc. (the Company ) received a written notification (the Letter
Estrella Immunopharma, Inc. filed 4
SEC form 4 filed by Estrella Immunopharma, Inc. (CIK 1844417) on 2026-08-26.
Estrella Immunopharma, Inc. filed 4
SEC form 4 filed by Estrella Immunopharma, Inc. (CIK 1844417) on 2026-08-25.
Estrella Immunopharma, Inc. filed 8-K
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 17, 2026, Estrella Immunopharma, Inc. (the Company ) received a written notification (the Letter )
ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A
0001172661-26-003573.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001172661-26-002144 0001601086 XXXXXXXX LIVE 1 Common Stock, par value $0.0001 per share 06/30/2026 0001844417 ESTRELLA IMMUNOPHA